Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04748861 · ClinicalTrials.gov registry record · NA
CYCLE-AD (CYcling to Cease or Limit the Effects of Alzheimer's Disease)
A NA study of High Intensity Exercise and Normal Cognition, sponsored by The Cleveland Clinic.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT04748861 is a NA study of High Intensity Exercise and Normal Cognition that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04748861, a NA study of High Intensity Exercise and Normal Cognition, is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of the CYCLE-AD trial is to determine the role of long-term, high intensity exercise in slowing or delaying the onset of cognitive and AD-related brain changes in e4 carriers. Successful translation and demonstration of the effectiveness of a scalable home-based exercise intervention capable of slowing or delaying disease onset will transform AD treatment, improve patient outcomes and quality of life, and reduce health care costs.
Conditions Studied
Interventions
- OTHER Indoor Cycling (IC)
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-10-20 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04748861
The ClinicalTrials.gov registry entry for NCT04748861 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with High Intensity Exercise appearing as the primary indexed condition, and to 1 intervention - of which Indoor Cycling (IC) is the first listed.
NCT04748861 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04748861 about?
NCT04748861 is a clinical study titled "CYCLE-AD (CYcling to Cease or Limit the Effects of Alzheimer's Disease)". The overall goal of the CYCLE-AD trial is to determine the role of long-term, high intensity exercise in slowing or delaying the onset of cognitive and AD-related brain changes in e4 carriers. Successful translation and demonstration of the effectiveness of a scalable home-based exercise interventio...
What is the current status of trial NCT04748861?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2021-10-20. Estimated completion is 2026-12-31.
What conditions does trial NCT04748861 study?
This clinical trial studies the following conditions: High Intensity Exercise, Normal Cognition, Exercise Intervention.
What interventions are being tested in trial NCT04748861?
The interventions under investigation include: Indoor Cycling (IC) (OTHER).
Who is sponsoring clinical trial NCT04748861?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04748861 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.